More Evidence for Neurofilament Light Chain as MS Biomarker

Tracking sNfL levels over time corresponds to multiple sclerosis disease course in a longitudinal study, but use of the blood biomarker for individual prognosis remains unclear.
Medscape Medical News

Source link

Related posts

clinical neurology; +323 new citations


Largest study finds CTE in 6% of athletes and non-athletes


Brain 'Pacemaker' Remodels Neural Networks to Stop Seizures


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy